Previous reports associated PD-L1 overexpression with poor prognosis in various cancers55–57; however, contradictory results were reported for breast cancer, HNSC, renal cell carcinoma, and upper tract urothelial carcinoma58–61. Here, CD274 is linked to breast carcinoma.